SCHEMBL8595997

SCHEMBL8595997

NC#CCCCCc1cccc2ccccc12.NC#CCCCCc1ccccc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2A6 P11509 1/20 0.40
MTNR1A P48039 1/20 0.38
SLC6A2 P23975 2/20 0.37
SLC6A4 P31645 2/20 0.37
GPR84 Q9NQS5 1/20 0.37
HPGD P15428 1/20 0.37
SSTR2 P30874 1/20 0.36
SSTR4 P31391 1/20 0.36
SIGMAR1 Q99720 3/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
SLC6A3 Q01959 1/20 0.36
AOC3 Q16853 1/20 0.36
DRD2 P14416 1/20 0.35
DRD4 P21917 1/20 0.35
DRD3 P35462 1/20 0.35
P2RX7 Q99572 1/20 0.35
PNMT P11086 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8811762 0.91 MTNR1A (0.43) CYP1A2MTNR1ASLC6A2SLC6A4GPR84
SCHEMBL8809778 0.88 TAAR1 (0.50) TAAR1CYP1A2SLC6A2SLC6A4CYP2C9
SCHEMBL9800436 0.74 CYP1A2 (0.58) CYP1A2MTNR1ASLC6A2SLC6A4GPR84
SCHEMBL1611571 0.72 GPR84 (0.44) CYP1A2MTNR1ASLC6A2SLC6A4GPR84
SCHEMBL3225205 0.72 MTNR1A (0.45) CYP1A2MTNR1AGPR84SIGMAR1CYP2C9
SCHEMBL3220289 0.71 MTNR1A (0.44) CYP1A2MTNR1AGPR84SIGMAR1CYP2C9
SCHEMBL1612033 0.71 GPR84 (0.43) CYP1A2MTNR1ASLC6A2SLC6A4GPR84
SCHEMBL11842602 0.71 MTNR1A (0.44) CYP1A2MTNR1AGPR84SIGMAR1CYP2C9
SCHEMBL1610299 0.71 GPR84 (0.43) CYP1A2MTNR1ASLC6A2SLC6A4GPR84
Hydrochloric Acid SCHEMBL10433751 0.71 SIGMAR1 (0.44) CYP1A2MTNR1ASLC6A2SLC6A4GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0840725-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1998-05-13 EP disclosed